Get the Stockscreener App
168.87
0.36%
0.40
Overview
News
Price History
Option Chain
Financials
Why MS Down?
Discussions
Forecast
Stock Split
Dividend History
Morgan Stanley stock is traded at $168.87, with a volume of 929.72K.
It is up +0.36% in the last 24 hours and up +3.09% over the past month.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 80,000 employees as of year-end 2024. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $7.9 trillion in client assets at the end of its most recent fiscal year. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with nearly $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.
See More
Previous Close:
$168.47
Open:
$168.885
24h Volume:
929.72K
Relative Volume:
0.17
Market Cap:
$268.56B
Revenue:
$113.10B
Net Income/Loss:
$16.33B
P/E Ratio:
17.33
EPS:
9.7425
Net Cash Flow:
$10.35B
1W Performance:
+2.20%
1M Performance:
+3.09%
6M Performance:
+31.67%
1Y Performance:
+29.03%
1-Day Range:
$168.69
$170.12
1-Week Range:
$165.87
$170.27
52-Week Range:
$94.33
$171.77
Morgan Stanley Stock (MS) Company Profile
Name
Morgan Stanley
Sector
Industry
Phone
212-761-4000
Address
1585 BROADWAY, NEW YORK, NY
Compare MS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MS
Morgan Stanley
|
168.98 | 267.75B | 113.10B | 16.33B | 10.35B | 9.7425 |
|
GS
Goldman Sachs Group Inc
|
813.21 | 243.20B | 126.58B | 16.67B | 57.26B | 49.23 |
|
SCHW
Charles Schwab Corp
|
92.56 | 164.70B | 27.16B | 8.23B | 20.55B | 4.2633 |
|
HOOD
Robinhood Markets Inc
|
124.66 | 110.82B | 4.23B | 2.19B | -4.36B | 2.4089 |
|
LPLA
Lpl Financial Holdings Inc
|
357.00 | 28.68B | 14.13B | 1.12B | 45.45M | 14.62 |
Morgan Stanley Stock (MS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-24-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-03-25 | Initiated | BMO Capital Markets | Outperform |
| Jul-09-25 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Nov-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Nov-15-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-04-24 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-24 | Downgrade | Goldman | Buy → Neutral |
| Aug-02-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jul-17-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Jan-17-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-17-24 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jan-09-24 | Downgrade | HSBC Securities | Buy → Hold |
| Nov-28-23 | Downgrade | Societe Generale | Buy → Hold |
| Nov-20-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Oct-23-23 | Downgrade | Odeon | Buy → Hold |
| Oct-20-23 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Oct-11-23 | Downgrade | UBS | Buy → Neutral |
| Sep-07-23 | Initiated | HSBC Securities | Buy |
| Jul-12-23 | Upgrade | Odeon | Hold → Buy |
| Jan-18-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-10-23 | Upgrade | Odeon | Sell → Hold |
| Jan-04-23 | Downgrade | Wolfe Research | Outperform → Underperform |
| Oct-05-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Sep-06-22 | Downgrade | Odeon | Hold → Sell |
| May-03-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-28-22 | Downgrade | Odeon | Buy → Hold |
| Dec-03-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Oct-04-21 | Reiterated | Jefferies | Buy |
| Sep-29-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-28-21 | Downgrade | Berenberg | Buy → Hold |
| Aug-13-21 | Downgrade | Seaport Global Securities | Buy → Neutral |
| Jul-07-21 | Resumed | Keefe Bruyette | Outperform |
| Jun-09-21 | Initiated | Jefferies | Buy |
| Apr-21-21 | Upgrade | Berenberg | Hold → Buy |
| Mar-02-21 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jan-06-21 | Initiated | Daiwa Securities | Neutral |
| Jan-04-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Nov-10-20 | Downgrade | Citigroup | Buy → Neutral |
| Oct-13-20 | Resumed | JP Morgan | Overweight |
| Jul-08-20 | Initiated | Seaport Global Securities | Buy |
| Jun-24-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jun-23-20 | Reiterated | UBS | Buy |
| May-21-20 | Upgrade | Odeon | Hold → Buy |
| Apr-14-20 | Upgrade | Societe Generale | Sell → Buy |
| Mar-13-20 | Upgrade | Goldman | Neutral → Buy |
| Mar-04-20 | Upgrade | Citigroup | Neutral → Buy |
| Feb-21-20 | Downgrade | DA Davidson | Buy → Neutral |
| Feb-20-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-21-20 | Downgrade | Citigroup | Buy → Neutral |
| Jan-17-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-13-20 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Jan-09-20 | Initiated | DA Davidson | Buy |
| Jan-06-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-29-19 | Downgrade | Odeon | Buy → Hold |
| Oct-10-19 | Upgrade | Sandler O'Neill | Hold → Buy |
| Jul-12-19 | Upgrade | Citigroup | Neutral → Buy |
| Apr-18-19 | Downgrade | Citigroup | Buy → Neutral |
View All
Morgan Stanley Stock (MS) Latest News
HASI price target raised to $47 from $44 at Morgan Stanley - TipRanks
TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target - GuruFocus
Watch Morgan Stanley's Wilson Sticks to His 7,800 Call for S&P 500 - Bloomberg.com
AI Data Center Opportunities Underpin Morgan Stanley's Bullish Stance On This Stock - Investor's Business Daily
Lam Research (NASDAQ:LRCX) Price Target Raised to $158.00 at Morgan Stanley - MarketBeat
Morgan Stanley's long position in H-shares of Cosco Shipping decreases to 6.16% on Nov 27HKEX - MarketScreener
‘It’s Not Even Close,’ Says Morgan Stanley About Nvidia Stock - TipRanks
Marvell price target raised to $86 from $76 at Morgan Stanley - Yahoo Finance
Morgan Stanley Sees More Balanced Risk/Reward for Donaldson (DCI) - Insider Monkey
Atmos Energy (ATO) Gets Target Boost as Morgan Stanley Revises Utility Sector Outlook - Insider Monkey
Morgan Stanley flags emerging opportunity in this sector By Investing.com - Investing.com Canada
Morgan Stanley Upgrades Bausch + Lomb to Overweight From Equal Weight, Adjusts PT to CA$29.41 From CA$19.64 - MarketScreener
Morgan Stanley Initiates Nova at Equalweight With $335 Price Target - MarketScreener
Morgan Stanley Downgrades Inspire Medical Systems to Equal Weight From Overweight, Adjusts PT to $130 From $105 - MarketScreener
Morgan Stanley Raises Price Target on Veracyte to $48 From $40, Keeps Underweight Rating - MarketScreener
Morgan Stanley Raises Price Target on Tempus AI to $85 From $80, Keeps Overweight Rating - MarketScreener
Morgan Stanley Adjusts Price Target on Becton, Dickinson and Company to $210 From $197, Maintains Overweight Rating - MarketScreener
Philip Morris International Presents at 2025 Morgan Stanley Global Consumer & Retail Conference - Business Wire
Morgan Stanley Raises Price Target on Natera to $265 From $220, Keeps Overweight Rating - MarketScreener
Morgan Stanley Adjusts Price Target on Lam Research to $158 From $137, Maintains Equalweight Rating - MarketScreener
Morgan Stanley Raises Price Target on IQVIA Holdings to $265 From $250, Keeps Overweight Rating - MarketScreener
Morgan Stanley Raises Price Target on Guardant Health to $130 From $105, Keeps Overweight Rating - MarketScreener
Morgan Stanley Raises Price Target on GRAIL to $110 From $85, Keeps Equalweight Rating - MarketScreener
Morgan Stanley Raises Price Target on Adaptive Biotechnologies to $21 From $16, Keeps Equalweight Rating - MarketScreener
Morgan Stanley Upgrades DexCom to Overweight From Equalweight, Adjusts PT to $75 From $63 - MarketScreener
Procept BioRobotics price target lowered to $51 from $56 at Morgan Stanley - TipRanks
Morgan Stanley Initiates Solaris Energy Infrastructure at Overweight With $68 Price Target - MarketScreener
Morgan Stanley Downgrades 10x Genomics to Equalweight From Overweight, Lifts Price Target to $20 From $17 - MarketScreener
Amid the Bitcoin pandemonium, on leading bank says investors need to get exposure - Proactive financial news
Morgan Stanley Adjusts Price Target on Applied Materials to $273 From $252, Maintains Overweight Rating - MarketScreener
Morgan Stanley Initiates Danaher at Overweight With $270 Price Target - MarketScreener
Morgan Stanley Initiates Waters at Equalweight With $423 Price Target - MarketScreener
Morgan Stanley Initiates Mettler-Toledo International at Equalweight With $1,550 Price Target - MarketScreener
Morgan Stanley Says Mortgage Aid May Halt China’s Housing Slump - Bloomberg.com
Solaris Energy initiated with an Overweight at Morgan Stanley - TipRanks
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com India
Morgan Stanley sees mainland China property slump extending into 2026 - South China Morning Post
Scandic Hotels stock downgraded by Morgan Stanley on UK budget impact - Investing.com
Morgan Stanley initiates coverage on Solaris Energy stock with Overweight rating - Investing.com
Morgan Stanley Raises Nvidia’s Price Target, Cites Persisting Dominance amid Soaring AI Demand - kaohoon international
Morgan Stanley Bullish on Citigroup (C) - MSN
Morgan Stanley Bullish on Eli Lilly and Company (LLY) - Finviz
Morgan Stanley Bearish on Progressive Corporation (PGR) - Insider Monkey
NVIDIA Corporation (NVDA) Morgan Stanley Raises Target Forecast - The Globe and Mail
Belite Bio Announces Pricing of $350.0 Million Underwritten Public Offering of American Depositary Shares - GlobeNewswire Inc.
Morgan Stanley Keeps Chord Energy (CHRD) Neutral Following Q3 Results - Insider Monkey
Morgan Stanley Turns Cautious on Corebridge (CRBG) After Key Transaction - Insider Monkey
Morgan Stanley Sees Industry Cycle Shifts, Cuts Jackson Financial (JXN) Price Target - Insider Monkey
Morgan Stanley’s Confidence Rises in American Healthcare REIT (AHR) Following Senior Housing Review - Insider Monkey
DT Midstream (DTM) Price Target Increased by Morgan Stanley After “Relatively In-Line” Q3 Earnings - Insider Monkey
Bank Of America Opens The Door To Crypto, Joining Morgan Stanley And BlackRock - Stocktwits
Morgan Stanley Stock (MS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.26%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):